The structure of a new cardenolide diglycoside and the biological activities of eleven cardenolide diglycosides from Nerium oleander
-
- Zhao Ming
- College of Chemistry and Chemical Engineering, Qiqihar University
-
- Bai Liming
- College of Chemistry and Chemical Engineering, Qiqihar University
-
- Toki Asami
- Graduate School of Science and Technology, Niigata University
-
- Hasegawa Ryo
- Graduate School of Science and Technology, Niigata University
-
- Sakai Jun-ichi
- Department of Chemistry and Chemical Engineering, Faculty of Engineering, Niigata University
-
- Hasegawa Toshiaki
- Mitsubishi Gas Chemical Company, Inc., Niigata Research Laboratory
-
- Ogura Hirotsugu
- Center for Biological Resources and Informatics, Tokyo Institute of Technology
-
- Kataoka Takao
- Center for Biological Resources and Informatics, Tokyo Institute of Technology
-
- Bai Yuhua
- Department of Medicinal Chemistry, Pharmaceutical Department, Daqing Campus of Harbin Medical University
-
- Ando Mariko
- Technical Division, School of Engineering, Tohoku University
-
- Hirose Katsutoshi
- KNC Laboratories Co., Ltd.
-
- Ando Masayoshi
- Department of Chemistry and Chemical Engineering, Faculty of Engineering, Niigata University
書誌事項
- タイトル別名
-
- The Structure of a New Cardenolide Diglycoside and the Biological Activities of Eleven Cardenolide Diglycosides from <i>Nerium oleander</i>
この論文をさがす
抄録
A new cardenolide diglycoside (1) was isolated from Nerium oleander together with ten known cardenolide diglycosides 2—11. The structure of compound 1 was established on the basis of their spectroscopic data. The in vitro anti-inflammatory activity of compounds 1—11 was examined on the basis of inhibitory activity against the induction of the intercellular adhesion molecule-1 (ICAM-1). Compounds 2—5 were active at an IC50 value of less than 0.8 μM. The cytotoxicity of compounds 1—11 was evaluated against three human cell lines normal human fibroblast cells (WI-38), malignant tumor cells induced from WI-38 (VA-13), and human liver tumor cells (HepG2). Compound 3 was active toward VA-13 cells, and compounds 2—5 were active toward HepG2 cells at IC50 values of less than 1.3 μM. The multidrug resistance (MDR)-reversal activity of compounds 1—11 was evaluated on the basis of the amount of calcein in MDR human ovarian cancer 2780AD cells in the presence of each compound. Compounds 1 and 8 showed moderate effects on calcein accumulation.
収録刊行物
-
- CHEMICAL & PHARMACEUTICAL BULLETIN
-
CHEMICAL & PHARMACEUTICAL BULLETIN 59 (3), 371-377, 2011
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204172666496
-
- NII論文ID
- 130000648947
-
- NII書誌ID
- AA00602100
-
- ISSN
- 13475223
- 00092363
-
- NDL書誌ID
- 10990546
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可